Cohance Lifesciences has appointed Umang Vohra as its new Chairman and CEO. With over 30 years of experience under his belt, including a tenure as the former MD and Global CEO of Cipla, Vohra is expected to bring significant industry knowledge and leadership to his new role.

Cohance Life's shares rose by 11% following the appointment of former Cipla CEO, Umang Vohra, as their new Executive Chairman, indicating investor confidence in his leadership skills.

Cohance Lifesciences has appointed former Cipla CEO, Umang Vohra, as their new Executive Chairman and Group CEO. This strategic move is aimed at boosting growth and improving strategic execution within the company.

Cohance confirms the recent surge in trading volume is attributed to broader market trends and not related to any imminent news or updates. Regular disclosures per UPSI guidelines are still being adhered to.